The incidence of heel pressure ulcers among orthopaedic patients who wear Prevalon boots or alternative heel protection: Exploratory study

Sage Products, LLC (now under Stryker)0 个研究点目标入组 40 人开始时间: 2017年12月4日最近更新: 2018年12月10日

适应症

试验速览

暂无简介。

•1. Over 18 years old
•2. In-patient within designated orthopaedic ward
•3. No visible heel pressure damage of category I heel ulcer only
•4. Considered vulnerable to developing pressure ulcers based on pressure ulcer risk assessment score and mobility or activity restrictions
•5. Able to provide informed consent
•6. No lower limb amputations
•7. Ankle-brachial pressure index (ABPI) between 0.8 and 1.3 at baseline

•1. Under 18 years old
•2. Visible heel pressure damage (category II and above)
•3. Not at risk of developing pressure ulcers
•4. Unable to provide informed consent
•5. Lower limb amputation
•6. ABPI under 0.8 or above 1.3 at baseline
•7. Patients who have participated in a clinical trial on wound healing within the past month
•8. Patients with a known history of non-adherence with medical treatment

发起方

Sage Products, LLC (now under Stryker)